It is observed that the ascites is a major complication of cirrhosis. Mortality from cirrhosis has increased from 6 per 100 000 population in 1993 to 12.7 per 100 000 population in 2000. Approximately 4% of the general population have an abnormal liver function or liver disease and approximately 10–20% of those with one of the three most common chronic liver diseases develop cirrhosis over a period of 10–20 years. The purpose of these guidelines is to promote a consistent clinical practice for management of ascites in cirrhosis and SBP.
Recommendations for management of ascites in cirrhosis: Diagnosis: It is recommended that patients give informed consent for a therapeutic or diagnostic paracentesis. The initial ascitic fluid analysis should include serum ascites albumin gradient in preference to ascitic protein. Ascitic amylase should be measured when there is clinical suspicion of…
